Brisbane, Australia-based digital health company ResApp has been talking up its Smartcough-C study — a multisite, double-blind study of the company’s smartphone-based respiratory analysis software — for a number of months. Conducted at Massachusetts General Hospital, Cleveland Clinic, and Texas Children’s Hospital, the trial was intended to support ResApp’s FDA submission for a number of...
DarioHealth launches in the UK. Israel-based DarioHealth, makers of a smartphone-connected glucometer, announced the launch of a direct-to-consumer channel in the United Kingdom. It is already available D2C in the US and Australia, but was previously available in the UK only through pharmacies and diabetes educators.
PlushCare launches telemedicine EMR. PlushCare, a D2C telemedicine service...
